Focus on the World Carotid Stents Market

Market Wire, March, 2008

Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue.

World Carotid Stents Market

This report analyzes the worldwide markets for Carotid Stents in Thousand Units and US$ Million. The report provides separate comprehensive analytics for the US, Europe and Rest of World. Annual forecasts are provided for each region for the period of 2004 through 2012. The report profiles 10 companies including many key and niche players worldwide such as Abbott Vascular, Boston Scientific Corporation, ev3, Inc., Johnson & Johnson, Cordis Corporation, Kensey Nash Corporation, and Medtronic, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-2

Quantitative Techniques & Analytics I-2

Product Definitions and Scope of Study I-3

Carotid Stents I-3

II. EXECUTIVE SUMMARY

1. Global Market Overview and Analysis II-1

Carotid Stents - A Nascent Market II-1

Current and Future Analysis II-1

US - Picking Pace II-1

2. Market Dynamics II-2

Factors Driving Carotid Stents Market II-2

Clinical Trials & Regulatory Approvals to Accelerate Adoption II-2

Broader Application of CAS II-2

Benefiting From Less-Invasive Nature of Procedure II-2

Acceptance by Various Medical Specialties II-2

Market Challenges II-3

Absence of Sufficient Clinical Data II-3

Surgeons Wary of High-Risk CAS Procedures II-3

Reimbursement Coverage Issue Hurdles Widespread Adoption II-3

Fighting for CAS Domain II-3

Training and Certification of Surgeons - A Major Hurdle II-4

Stenting Procedure for Transient Ischemic Attacks - A Continuing Dilemma II-4

3. Competitive Scenario II-5

Table 1: Worldwide Carotid Stents Market (2006-2007E): Market Share of Leading Players by Revenues for Boston Scientific, Abbott Vascular/Guidant, Johnson & Johnson/Cordis, Medtronic and Others (includes corresponding Graph/Chart) II-5

4. Product Overview II-6

Carotid Stents - An Introduction II-6

How is Carotid Stenting Helpful? II-6

Carotid Stents - A Viable Alternative to Surgical Procedures II-6

Carotid Stenting Lowers Depression Symptoms!!! II-7

Embolic Protection Devices II-7

Filter-Based EPD Systems II-7

Balloon Occlusion Devices II-7

Basic Carotid Stents Products II-8

Stent Design II-8

Carotid Stents of Major Companies Available in the Market II-8

Carotid Stents Under Development II-9

Diagnosis of Carotid Artery Blockage II-9

Eligibility Criteria for Carotid Stenting Procedure II-10

Potential Candidates for Carotid Stenting II-10

Patients with High Surgical Risk II-10

Non-Candidates for Carotid Stenting II-10

Risk Factors Associated with Carotid Stenting Procedures II-10

Carotid Artery Stenting (CAS) - The Procedure II-11

Catheter Insertion Via Femoral Artery II-11

Advantages of the Procedure II-12

Post-Stenting Complications II-12

5. Overview of Cardiac Diseases II-13

Cerebrovascular Disease II-13

Carotid Artery Disease II-13

Major Symptoms II-13

Carotid Artery Stenosis II-13

Atherosclerosis II-14

Treatment Procedures for Carotid Artery Disease II-14

Carotid Endarterectomy (CEA) II-14

Drawbacks of CEA Procedure II-14

Carotid Artery Stenting (CAS) II-15

CAS Versus CEA II-15

Table 2: Worldwide Carotid Interventions (2006-2008E)): Percentage Breakdown of Number of Procedures for Carotid Endarterectomy and Carotid Stenting (includes corresponding Graph/Chart) II-16

Comparative Study of CAS and CEA Devices II-16

Benefits of CAS over CEA II-16

Drawbacks for CAS Penetration II-17

Risks Associated with CEA and CAS II-17

6. Major Clinical Trials/Studies II-18

Clinical Trials - Key to Higher Adoption of Carotid Stents II-18

Major Clinical Trials & Stent Devices Used II-18

Guidant's CAPTURE Study II-19

CAPTURE Study Results Hold Promise for Asymptomatic Patients II-19

Boston Scientific's BEACH Trial II-20

Abbott's ACT I Trial II-20

CREST Clinical Trial II-20

J&J's SAPPHIRE Clinical Trial II-21

SAPPHIRE Study Proves Effectiveness of CAS in High-Risk Patients II-21

Other Trials II-21

Medtronic's MAVErIC Trials Validate the Efficiency of Exponent Carotid Stent II-21

University of Massachusetts Conduct CAS Efficacy Study in Elderly Patients II-22

CaRESS Study II-22

7. Product Launches/Approvals II-23

KNC Obtains Expanded CE Mark Clearance for TriActiv® ProGuard(TM) II-23

FDA Approves Protege® RX Carotid Stent from ev3 II-23

Abbott Introduces Emboshield® PRO Embolic Protection System in Europe II-24

Cordis Gains FDA Approval for PRECISE® & ANGIOGUARD® Devices II-24

Medtronic Obtains CE Mark Approval for Exponent® RX Carotid Stent II-24

FDA Approves Boston Scientific's FilterWire EZ(TM) Embolic Protection System II-25

Abbott's Xact® Carotid Stent Receives FDA Approval II-25

EndoTex's NexStent(TM) Receives CE Mark Approval II-25

KNC Seeks FDA Approval for TriActiv LFX Trial II-25

Guidant's RX ACCULINK(TM) Carotid Stent System Gets FDA Clearance II-26

ev3's Protege GPS Receives CE Mark Approval II-26